Table 1.
Patient characteristics
| Characteristics | |
|---|---|
| Age (years) | |
| Mean ± SD | 61 ± 14.9 |
| Range | 25–83 |
| Sex, n(%) | |
| Male | 30(50) |
| Female | 30(50) |
| Masaoka stage, n (%) | |
| I | 47(78) |
| II | 4(7) |
| III | 3(5) |
| IVa | 4(7) |
| IVb | 2(3) |
| TNM stage, n(%) | |
| I | 51(85) |
| II | 1(2) |
| IIIa | 2(3) |
| IIIb | 0(0) |
| IVa | 5(8) |
| IVb | 1(2) |
| Thymoma-related syndrome, n(% | |
| Myasthenia gravis | 11(18) |
| Pure Red Cell Aplasia | 1(2) |
| Lichen planus | 1(2) |
| Histological type, n(%) | |
| A | 6(10) |
| AB | 14(23) |
| B1 | 11(18) |
| B2 | 22(37) |
| B3 | 7(12) |
| Tumor size (cm) | |
| Mean ± SD | 5.4 ± 2.2 |
| Range | 1.1–10 |
| Operative approach, n(%) | |
| Median sternotomy | 39(65) |
| Lateral incision | 1(2) |
| Clamshell incision | 5(8) |
| Video assisted thoracoscopic surgery | 15(25) |
| Operative procedure, n(%) | |
| Extended thymectomy | 17(28) |
| Thymomectomy | 43(72) |
| Operative time (min) | |
| Mean ± SD | 184 ± 79 |
| Range | 40–362 |
| Blood loss (g) | |
| Mean ± SD | 94 ± 78 |
| Range | 1–360 |
| Postoperative treatment, n(%) | |
| Radiotherapy | 12(20) |
| Chemotherapy | 4(7) |
| Resection status, n(%) | |
| Complete resection | 53(88) |
| Incomplete resection | 7(12) |
| Initial relapse site (cases) | |
| Pleural dissemination | 6 |
| Pulmonary metastasis | 1 |
| Local | 1 |
| Treatment for recurrence (cases)(overlap) | |
| Surgery | 1 |
| Chemotherapy | |
| protocol | |
| ADOC | 2 |
| CBDCA+PTX | 1 |
| Cisplatin + Etoposide | 1 |
| Radiation | 4 |
ADOC Adriamycin + cisplatin + vincristine + cyclophosphamide, CBDCA carboplatin, PTX paclitaxel, SD standard deviation, TNM tumor, node, metastasis